The Efficacy of Individual Cognitive Behavioral Therapy for Eating Disorders: A Meta-Analysis of Randomized Controlled Trials
Abstract
ABSTRACT Background This meta‐analysis aims to provide an update on the efficacy of individual cognitive behavioral therapy (CBT) for eating disorders (EDs) in the light of recent advances in the field, particularly the emergence of new approaches like self‐help. Method We conducted multivariate multilevel meta‐analyses using data from 42 randomized controlled trials to evaluate the efficacy of individual CBT for anorexia nervosa, bulimia nervosa, binge‐eating disorder, and mixed eating disorder samples. Outcomes included ED pathology, the frequency of binge eating and compensatory behaviors, and body mass index. The type of comparison group, treatment format, treatment duration, baseline ED severity, and year of publication were analyzed as potential moderators. Results CBT was more efficacious with regard to all relevant outcomes than waitlist conditions. For anorexia nervosa, there were no studies using a waitlist condition. CBT was not superior to active treatments for any disorder or any outcome. Therapist‐led treatment for bulimia nervosa showed a significant effect for all outcomes, while self‐help formats only did for some outcomes. Treatment duration and publication year were significant moderators for mixed EDs, while greater baseline severity was associated with larger effects of CBT for binge‐eating disorder. Discussion The variety of active controls impeded comparative analyses of CBT with specific active controls. Effects were heterogeneous; the majority of…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.